Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EZETIMIBE Cause Hepatic function abnormal? 84 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Hepatic function abnormal have been filed in association with EZETIMIBE (Ezetimibe). This represents 0.6% of all adverse event reports for EZETIMIBE.

84
Reports of Hepatic function abnormal with EZETIMIBE
0.6%
of all EZETIMIBE reports
9
Deaths
50
Hospitalizations

How Dangerous Is Hepatic function abnormal From EZETIMIBE?

Of the 84 reports, 9 (10.7%) resulted in death, 50 (59.5%) required hospitalization, and 24 (28.6%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EZETIMIBE. However, 84 reports have been filed with the FAERS database.

What Other Side Effects Does EZETIMIBE Cause?

Myalgia (2,066) Fatigue (876) Drug ineffective (812) Arthralgia (766) Dyspnoea (766) Nausea (742) Dizziness (717) Diarrhoea (688) Headache (626) Malaise (591)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which EZETIMIBE Alternatives Have Lower Hepatic function abnormal Risk?

EZETIMIBE vs EZETIMIBE\ROSUVASTATIN EZETIMIBE vs EZETIMIBE\SIMVASTATIN EZETIMIBE vs EZOGABINE EZETIMIBE vs FACTOR XIII CONCENTRATE EZETIMIBE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI

Related Pages

EZETIMIBE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal EZETIMIBE Demographics